HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frank M Torti Selected Research

Apoferritins

1/2017DCYTB is a predictor of outcome in breast cancer that functions via iron-independent mechanisms.
1/2015Cytoprotective Effect of Ferritin H in Renal Ischemia Reperfusion Injury.
1/2014IRP2 regulates breast tumor growth.
8/2010Ferritin H induction by histone deacetylase inhibitors.
10/2005TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis.
1/2003Nrf2 mediates the induction of ferritin H in response to xenobiotics and cancer chemopreventive dithiolethiones.
1/2003Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Frank M Torti Research Topics

Disease

53Neoplasms (Cancer)
12/2020 - 02/2002
14Prostatic Neoplasms (Prostate Cancer)
10/2019 - 10/2003
13Breast Neoplasms (Breast Cancer)
01/2018 - 10/2008
12Neoplasm Metastasis (Metastasis)
01/2018 - 10/2003
5Neurodegenerative Diseases (Neurodegenerative Disease)
01/2014 - 01/2003
5Kidney Neoplasms (Kidney Cancer)
11/2010 - 12/2002
5Iron Overload
12/2009 - 07/2002
4Inflammation (Inflammations)
08/2010 - 11/2004
4Iron Deficiencies
08/2010 - 01/2003
4Renal Cell Carcinoma (Grawitz Tumor)
04/2008 - 07/2003
3Ovarian Neoplasms (Ovarian Cancer)
10/2019 - 01/2018
3Disease Progression
10/2019 - 03/2004
3Cardiovascular Diseases (Cardiovascular Disease)
01/2014 - 12/2009
2Carcinogenesis
01/2018 - 01/2016
2Anemia
01/2016 - 01/2009
2Chronic Disease (Chronic Diseases)
01/2014 - 01/2009
2Atherosclerosis
01/2014 - 12/2009
2Leukemia
08/2013 - 01/2010
2Lymphoma (Lymphomas)
08/2013 - 01/2010
2Pathologic Processes
08/2010 - 05/2009
2Pain (Aches)
09/2006 - 05/2004
1Hemochromatosis (Bronze Diabetes)
01/2016
1Head and Neck Neoplasms (Head and Neck Cancer)
05/2015
1Acute Kidney Injury (Acute Renal Failure)
01/2015
1Ischemia
01/2015
1Reperfusion Injury
01/2015
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2014
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2014
1Hypoxia (Hypoxemia)
05/2013
1Myocardial Infarction
01/2013
1Necrosis
04/2012
1Hyperthermia
04/2012

Drug/Important Bio-Agent (IBA)

37IronIBA
12/2020 - 07/2002
17Proteins (Proteins, Gene)FDA Link
10/2019 - 01/2003
9Chelating AgentsIBA
01/2013 - 07/2002
8Ferritins (Ferritin)IBA
01/2015 - 01/2003
7HepcidinsIBA
01/2019 - 08/2010
7ApoferritinsIBA
01/2017 - 01/2003
6metal transporting protein 1 (ferroportin)IBA
10/2019 - 08/2010
6tachpyrIBA
12/2005 - 06/2003
4EnzymesIBA
10/2019 - 02/2002
4Messenger RNA (mRNA)IBA
01/2018 - 08/2010
4Doxorubicin (Adriamycin)FDA LinkGeneric
08/2013 - 09/2006
4AndrogensIBA
09/2006 - 10/2003
3Iron Regulatory Protein 2IBA
10/2017 - 01/2014
3Phosphotransferases (Kinase)IBA
01/2017 - 11/2005
3Hormones (Hormone)IBA
06/2015 - 05/2007
3Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
10/2011 - 02/2008
3Carbon Nanotubes (Carbon Nanotube)IBA
10/2011 - 01/2007
2MetalsIBA
10/2020 - 11/2005
2Reactive Oxygen Species (Oxygen Radicals)IBA
10/2020 - 12/2009
2Transcription Factors (Transcription Factor)IBA
10/2019 - 11/2004
2Peptide Hormones (Polypeptide Hormones)IBA
01/2018 - 01/2013
2Interleukin-6 (Interleukin 6)IBA
01/2018 - 06/2015
2Transferrin Receptors (Transferrin Receptor)IBA
01/2017 - 01/2014
2Free RadicalsIBA
01/2016 - 01/2014
2Oxidants (Oxidizing Agents)IBA
01/2015 - 07/2002
2Doxycycline (Periostat)FDA LinkGeneric
01/2015 - 12/2008
2Phenobarbital (Luminal)FDA Link
01/2015 - 01/2014
2Vitamin DFDA LinkGeneric
01/2014 - 12/2005
2AnthracyclinesIBA
08/2013 - 01/2010
2GadoliniumIBA
08/2013 - 09/2010
2angiotensin I (1-7)IBA
01/2013 - 01/2013
2Pharmaceutical PreparationsIBA
12/2009 - 06/2003
2CurcuminIBA
01/2009 - 04/2006
2Prostate-Specific Antigen (Semenogelase)IBA
09/2006 - 03/2004
1Biological ProductsIBA
10/2020
1Monounsaturated Fatty AcidsIBA
10/2019
1Stearoyl-CoA DesaturaseIBA
10/2019
1LipidsIBA
10/2019
1Cyclin-Dependent Kinases (cdk Proteins)IBA
10/2019
1Kruppel-Like Factor 6IBA
10/2019
1Conditioned Culture MediaIBA
01/2019
1Fatty Acids (Saturated Fatty Acids)IBA
01/2018
1antineoplaston A10 (A 10)IBA
01/2018
1Growth Differentiation Factor 15IBA
01/2018
1Heme (Haem)IBA
01/2017
1SulfurIBA
01/2017
1MicroRNAs (MicroRNA)IBA
01/2016
1Small Interfering RNA (siRNA)IBA
05/2015
12-nonenalIBA
01/2015
1Caspase 3 (Caspase-3)IBA
01/2015
1seocalcitolIBA
01/2014
1Cytostatic AgentsIBA
01/2014
1Brain Natriuretic Peptide (Natrecor)FDA Link
08/2013
1Troponin IIBA
08/2013
1Eosine Yellowish-(YS) (Eosin)IBA
01/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2013
1Estrogens (Estrogen)FDA Link
01/2013
1Hematoxylin (Haematoxylon)IBA
01/2013
1DNA (Deoxyribonucleic Acid)IBA
12/2012
1Dutasteride (Avodart)FDA Link
12/2012

Therapy/Procedure

19Therapeutics
10/2020 - 06/2003
4Drug Therapy (Chemotherapy)
08/2013 - 10/2003
2Lasers (Laser)
10/2011 - 08/2009
2Stem Cell Transplantation
10/2009 - 05/2009
2Nephrectomy
07/2003 - 12/2002
2Radiofrequency Ablation
07/2003 - 12/2002
1Photothermal Therapy
04/2012
1Radiotherapy
04/2012